LycopsamineCAS# 10285-07-1 |
- Intermedine
Catalog No.:BCN1997
CAS No.:10285-06-0
- Indicine
Catalog No.:BCN1995
CAS No.:480-82-0
- Echinatine
Catalog No.:BCN1968
CAS No.:480-83-1
- Rinderine
Catalog No.:BCN1971
CAS No.:6029-84-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 10285-07-1 | SDF | Download SDF |
PubChem ID | 107938 | Appearance | White-beige powder |
Formula | C15H25NO5 | M.Wt | 299.37 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Synonyms | Retronecine 9-(-)-viridiflorate | ||
Solubility | Soluble in chloroform | ||
Chemical Name | [(7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate | ||
SMILES | CC(C)C(C(C)O)(C(=O)OCC1=CCN2C1C(CC2)O)O | ||
Standard InChIKey | SFVVQRJOGUKCEG-ZGFBFQLVSA-N | ||
Standard InChI | InChI=1S/C15H25NO5/c1-9(2)15(20,10(3)17)14(19)21-8-11-4-6-16-7-5-12(18)13(11)16/h4,9-10,12-13,17-18,20H,5-8H2,1-3H3/t10-,12+,13+,15-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | TLC densitometric method for screening of lycopsamine in comfrey root (Symphytum officinale L.) extracts using retrorsine as a reference compound.[Pubmed: 25531790]Acta Pharm. 2014 Dec;64(4):503-8.Due to severe toxicity of pyrrolizidine alkaloids, their quantification in medicinal products is very important. The idea of this research was to use retrorsine as a surrogate reference compound instead of Lycopsamine reference or Lycopsamine isolated from comfrey.
|
In vivo | The comparative toxicity of a reduced, crude comfrey (Symphytum officinale) alkaloid extract and the pure, comfrey-derived pyrrolizidine alkaloids, lycopsamine and intermedine in chicks (Gallus gallus domesticus).[Pubmed: 26177929]J Appl Toxicol. 2016 May;36(5):716-25.Comfrey (Symphytum officinale), a commonly used herb, contains dehydropyrrolizidine alkaloids that, as a group of bioactive metabolites, are potentially hepatotoxic, pneumotoxic, genotoxic and carcinogenic. Consequently, regulatory agencies and international health organizations have recommended comfrey be used for external use only. However, in many locations comfrey continues to be ingested as a tisane or as a leafy vegetable.
|
Structure Identification | Phytochem Anal. 2014 Sep-Oct;25(5):429-38.Semi-automated separation of the epimeric dehydropyrrolizidine alkaloids lycopsamine and intermedine: preparation of their N-oxides and NMR comparison with diastereoisomeric rinderine and echinatine.[Pubmed: 24816769]To investigate methods for the separation of gram-scale quantities of the epimeric dehydropyrrolizidine alkaloids Lycopsamine and intermedine and to compare their NMR spectroscopic data with those of their heliotridine-based analogues echinatine and rinderine. |
Lycopsamine Dilution Calculator
Lycopsamine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3403 mL | 16.7017 mL | 33.4035 mL | 66.807 mL | 83.5087 mL |
5 mM | 0.6681 mL | 3.3403 mL | 6.6807 mL | 13.3614 mL | 16.7017 mL |
10 mM | 0.334 mL | 1.6702 mL | 3.3403 mL | 6.6807 mL | 8.3509 mL |
50 mM | 0.0668 mL | 0.334 mL | 0.6681 mL | 1.3361 mL | 1.6702 mL |
100 mM | 0.0334 mL | 0.167 mL | 0.334 mL | 0.6681 mL | 0.8351 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Intermedine
Catalog No.:BCN1997
CAS No.:10285-06-0
- MLN8237 (Alisertib)
Catalog No.:BCC2166
CAS No.:1028486-01-2
- Ganolactone B
Catalog No.:BCN2872
CAS No.:1028449-53-7
- Moracin P
Catalog No.:BCN3289
CAS No.:102841-46-3
- Mulberroside C
Catalog No.:BCN6344
CAS No.:102841-43-0
- Mulberroside A
Catalog No.:BCN6343
CAS No.:102841-42-9
- D-Pinitol
Catalog No.:BCN5842
CAS No.:10284-63-6
- BEZ235 Tosylate
Catalog No.:BCC1416
CAS No.:1028385-32-1
- VUF 10460
Catalog No.:BCC6285
CAS No.:1028327-66-3
- Dihydrocinchonamine
Catalog No.:BCN5841
CAS No.:10283-68-8
- RuBi-GABA
Catalog No.:BCC6012
CAS No.:1028141-88-9
- [D-p-Cl-Phe6,Leu17]-VIP
Catalog No.:BCC5968
CAS No.:102805-45-8
- 17-Hydroxy sprengerinin C
Catalog No.:BCN2755
CAS No.:1029017-75-1
- Pexidartinib (PLX3397)
Catalog No.:BCC6405
CAS No.:1029044-16-3
- MDL 73005EF hydrochloride
Catalog No.:BCC6636
CAS No.:102908-60-1
- Scutellaric acid
Catalog No.:BCN5843
CAS No.:102919-76-6
- INCB28060
Catalog No.:BCC3793
CAS No.:1029712-80-8
- Trelagliptin succinate
Catalog No.:BCC2015
CAS No.:1029877-94-8
- H-DL-Phg-OH
Catalog No.:BCC3317
CAS No.:103-01-5
- Monobenzone
Catalog No.:BCC3818
CAS No.:103-16-2
- Methyl cinnamate
Catalog No.:BCN5043
CAS No.:103-26-4
- Ethyl cinnamate
Catalog No.:BCN5044
CAS No.:103-36-6
- Benzyl cinnamate
Catalog No.:BCN5042
CAS No.:103-41-3
- Scutebarbatine M
Catalog No.:BCN8327
CAS No.:960302-92-5
Semi-automated separation of the epimeric dehydropyrrolizidine alkaloids lycopsamine and intermedine: preparation of their N-oxides and NMR comparison with diastereoisomeric rinderine and echinatine.[Pubmed:24816769]
Phytochem Anal. 2014 Sep-Oct;25(5):429-38.
INTRODUCTION: The diversity of structure and, particularly, stereochemical variation of the dehydropyrrolizidine alkaloids can present challenges for analysis and the isolation of pure compounds for the preparation of analytical standards and for toxicology studies. OBJECTIVE: To investigate methods for the separation of gram-scale quantities of the epimeric dehydropyrrolizidine alkaloids Lycopsamine and intermedine and to compare their NMR spectroscopic data with those of their heliotridine-based analogues echinatine and rinderine. METHODS: Lycopsamine and intermedine were extracted, predominantly as their N-oxides and along with their acetylated derivatives, from commercial samples of comfrey (Symphytum officinale) root. Alkaloid enrichment involved liquid-liquid partitioning of the crude methanol extract between dilute aqueous acid and n-butanol, reduction of N-oxides and subsequent continuous liquid-liquid extraction of free base alkaloids into CHCl3 . The alkaloid-rich fraction was further subjected to semi-automated flash chromatography using boronated soda glass beads or boronated quartz sand. RESULTS: Boronated soda glass beads (or quartz sand) chromatography adapted to a Biotage Isolera Flash Chromatography System enabled large-scale separation (at least up to 1-2 g quantities) of Lycopsamine and intermedine. The structures were confirmed using one- and two-dimensional (1) H- and (13) C-NMR spectroscopy. Examination of the NMR data for Lycopsamine, intermedine and their heliotridine-based analogues echinatine and rinderine allowed for some amendments of literature data and provided useful comparisons for determining relative configurations in monoester dehydropyrrolizidine alkaloids. A similar NMR comparison of Lycopsamine and intermedine with their N-oxides showed the effects of N-oxidation on some key chemical shifts. A levorotatory shift in specific rotation from +3.29 degrees to -1.5 degrees was observed for Lycopsamine when dissolved in ethanol or methanol respectively. CONCLUSION: A semi-automated flash chromatographic process using boronated soda glass beads was standardised and confirmed as a useful, larger scale preparative approach for separating the epimers Lycopsamine and intermedine. The useful NMR correlations to stereochemical arrangements within this specific class of dehydropyrrolizidine alkaloid cannot be confidently extrapolated to other similar dehydropyrrolizidine alkaloids. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.
TLC densitometric method for screening of lycopsamine in comfrey root (Symphytum officinale L.) extracts using retrorsine as a reference compound.[Pubmed:25531790]
Acta Pharm. 2014 Dec;64(4):503-8.
Due to severe toxicity of pyrrolizidine alkaloids, their quantification in medicinal products is very important. The idea of this research was to use retrorsine as a surrogate reference compound instead of Lycopsamine reference or Lycopsamine isolated from comfrey. A method for the analysis of Lycopsamine in extracts of comfrey roots was developed and validated, employing thin layer chromatography, derivatisation with Dann-Mattocks reagent followed by densitometric analysis. The new method showed linearity within 0.70 to 7.0 mug of Lycopsamine per application of 10 muL of a solution. It has also been proven to be specific and precise (repeatability RSD 2-4 % within the plate). The method was successfully employed for quantification of Lycopsamine in comfrey root and comfrey root medicinal products such as ointments.
The comparative toxicity of a reduced, crude comfrey (Symphytum officinale) alkaloid extract and the pure, comfrey-derived pyrrolizidine alkaloids, lycopsamine and intermedine in chicks (Gallus gallus domesticus).[Pubmed:26177929]
J Appl Toxicol. 2016 May;36(5):716-25.
Comfrey (Symphytum officinale), a commonly used herb, contains dehydropyrrolizidine alkaloids that, as a group of bioactive metabolites, are potentially hepatotoxic, pneumotoxic, genotoxic and carcinogenic. Consequently, regulatory agencies and international health organizations have recommended comfrey be used for external use only. However, in many locations comfrey continues to be ingested as a tisane or as a leafy vegetable. The objective of this work was to compare the toxicity of a crude, reduced comfrey alkaloid extract to purified Lycopsamine and intermedine that are major constituents of S. officinale. Male, California White chicks were orally exposed to daily doses of 0.04, 0.13, 0.26, 0.52 and 1.04 mmol Lycopsamine, intermedine or reduced comfrey extract per kg bodyweight (BW) for 10 days. After another 7 days chicks were euthanized. Based on clinical signs of poisoning, serum biochemistry, and histopathological analysis the reduced comfrey extract was more toxic than Lycopsamine and intermedine. This work suggests a greater than additive effect of the individual alkaloids and/or a more potent toxicity of the acetylated derivatives in the reduced comfrey extract. It also suggests that safety recommendations based on purified compounds may underestimate the potential toxicity of comfrey.